Cargando…
SUN-578 Role of Linagliptin on CD34+ Endothelial Progenitor Cells and Arterial Stiffness in Renal Function Impaired Type 2 Diabetes Subjects
Introduction: Endothelial Progenitor cells (EPCs) has been shown to be dysfunctional in both Type 2 Diabetes and Chronic Kidney Disease (CKD) leading to poor regeneration of endothelium and renal tubules. EPCs have been shown to be a robust cardiovascular disease (CVD) risk indicator. DPP4 inhibitor...
Autores principales: | Awal, Hassan, Domingues, Cleyton, Dore, Fiona, Kundu, Nabanita, Ahmadi, Neeki, Magan, Fosso, Witkin, Linda, Batistich, Bethany, Safai, Shauna, Amdur, Richard, Sen, Sabyasachi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209126/ http://dx.doi.org/10.1210/jendso/bvaa046.430 |
Ejemplares similares
-
Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial
por: Awal, Hassan B., et al.
Publicado: (2020) -
The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
por: Dore, Fiona J., et al.
Publicado: (2018) -
Reassessing the effects of continuous positive airway pressure (CPAP) on arterial stiffness and peripheral blood derived CD34+ progenitor cells in subjects with sleep apnea
por: Domingues, Cleyton C., et al.
Publicado: (2019) -
Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity
por: Domingues, Cleyton C., et al.
Publicado: (2019) -
Use of p53‐Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease
por: Kundu, Nabanita, et al.
Publicado: (2017)